At a glance
Our 2022 Performance Overview
172.0 £m See-through Revenue*
30.3 £m Underlying Profit Before Tax*
4.28p Underlying Basic EPS*
167.4 £m Statutory Revenue
5.2 £m Reported Profit Before Tax
*Non-IFRS Alternative Performance Measures (‘APMs’). See-through revenue includes all sales from Nizoral as if they had been invoiced by Alliance as principal. For statutory accounting purposes the product margin relating to Nizoral sales made on an agency basis is included within Revenue, in line with IFRS 15.
Results centreBuilt for modern business
An inter-connected network of people and brands
A global range of products delivering outstanding value. Many partners working together; one team, achieving more.
Downloads & useful links
2022 Final Results Presentation
DownloadREGULATORY NEWS
- 01 DEC 23 Total Voting Rights
- 09 NOV 23 Notification of Major Holdings
- 07 NOV 23 Appointment of Non-Executive Directors